Linda O'Keefe

Chemical Angels is a network of accredited investors. We invest our own capital into Chemistry enabled companies. Please see the Chemical Angels Network (LinkedIn Group) for interactive discussions and announcements. We serve the investor and the entrepreneur by presenting quality investment opportunities to qualified investors. Our mission is to provide financial capital and experienced mentorship to early stage chemical companies. Companies can submit applications for funding and investors can apply for membership at www.ChemicalAngels.com

Chemical Angels is a network of accredited investors. We invest our own capital into Chemistry enabled companies. Please see the Chemical Angels Network (LinkedIn Group) for interactive discussions and announcements. We serve the investor and the entrepreneur by presenting quality investment opportunities to qualified investors. Our mission is to provide financial capital and experienced mentorship to early stage chemical companies. Companies can submit applications for funding and investors can apply for membership at www.ChemicalAngels.com

Elevate Ventures invests in high-potential cross-sector innovative companies with a minimum $500M TAM at the pre-seed, seed, and early stages. Over the last 10+ years, Elevate has invested capital in more than 500 Indiana-based startups and provided assistance to nearly 4,000 companies across 86 counties. We are the #1 Most Active Seed & Early-Stage Venture Capital Firm in the Great Lakes Region. The foundation is set for an even more impactful 10 years ahead with Indiana’s potential to become the Innovation Capital of the World®. To drive our state closer to this vision, Elevate focuses on three areas: • Community: Build Collaborative Communities • Capital: Invest in High-Potential Companies • Acceleration: Provide World-Class Programming Learn more at https://elevateventures.com

Gryphon Investors is a leading middle-market private investment firm focused on building and growing profitable, market-leading companies in the Business Services, Consumer, Healthcare, Industrial Growth, Software & Technology Solutions & Services sectors. As of June 30, 2025, Gryphon manages $10+ billion from our Flagship, Gryphon Heritage, and Junior Capital Funds. The firm’s highly-differentiated and fully-integrated “Deal-Ops” model combines industry and functional operating expertise across the disciplines of general management, human capital, IT, AI, and finance and accounting.

We leverage our passion, expertise, deep experience and network to help advance new technologies and build market leading companies. Delphi has helped several drugs achieve market approval. Our firm has enabled dozens of companies to expand therapeutic access for patients who need less invasive procedures. The firm is based in the San Francisco Bay Area, California, USA.